Infectious Diseases 2019

Infectious Diseases 2019

EFSA/ECDC: Summary report on antimicrobial resistance in zoonotic bacteria - 2017

2 March, 2019

Zoonotic diseases, such as campylobacteriosis and salmonellosis, continue to build resistance against common antimicrobial drugs, according to a new report from the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) - “The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017”. 
The joint report presents data collected from 28 EU Member States from humans, pigs and calves under one year of age. The authors say the report confirms the rise in antibiotic resistance already identified in previous years.
According to the report, resistance to fluoroquinolones (such as ciprofloxacin) is so high in Campylobacter bacteria in some countries that these antimicrobials no longer work for the treatment of severe campylobacteriosis cases.
Most countries reported that Salmonella in humans is increasingly resistant to fluoroquinolones. Multidrug resistance (resistance to three or more antimicrobials) is high in Salmonella found in humans (28.3%) and animals, particularly in S. Typhimurium.
Very high to extremely high resistance levels to ciprofloxacin were reported in Campylobacter jejuni isolates from humans by all countries except Denmark, Iceland, Ireland, Norway and the United Kingdom. However, combined resistance to critically important antimicrobials was very low to low in Salmonella and Campylobacter from humans and animals and in indicator E. coli from animals. Most countries reported that Salmonella in humans is increasingly resistant to fluoroquinolones.
Poultry accounts for about 60–70% of campylobacter infections in humans.